Skip to Main Content

Author Details

Richard A Rawson
David Geffen School of Medicine, University of California los angeles
1970
231
51
PMIDPaper TitleJournal TitlePublished Year
36931604Stimulant use among patients in opioid treatment settings: Provider perspectives.J Subst Use Addict Treat2023
37573952The urgent need for contingency management among Tribal communities in the United States: Considerations for implementation, policy, and sovereignty.Prev Med2023
37499918A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated.Prev Med2023
37494973US state laws relevant to incentives for health behavior: A qualitative analysis.Prev Med2023
35841323Addressing Methamphetamine Use in Primary Care: Provider Perspectives.J Addict Med2023
37061191Expanding access to treatment for stimulant use disorder in a frontier state: A qualitative study of contingency management and TRUST program implementation in Montana.J Subst Use Addict Treat2023
37311520The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.J Subst Use Addict Treat2023
37468073The fourth wave of the overdose crisis: Examining the prominent role of psychomotor stimulants with and without fentanyl.Prev Med2023
36745163Contingency Management for Stimulant Use Disorder: Progress, Challenges, and Recommendations.J Ambul Care Manage2023
34696944Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021).Drug Alcohol Depend2022
36962600Perceived benefits, challenges, and recommendations for HIV research dissemination and implementation science efforts in Tanzania: Findings from the HIV/AIDS Research Forum brainstorming session.PLOS Glob Public Health2022
34979421Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders.Drug Alcohol Depend2022
34999268Craving among individuals with stimulant use disorder in residential social model-based treatment - Can exercise help?Drug Alcohol Depend2022
32415721Effect of screening, brief intervention and referral to treatment for unhealthy alcohol and other drug use in mental health treatment settings: a randomized controlled trial.Addiction2021
33771278A randomized comparison of 4 vs. 16 weeks of psychosocial treatment for stimulant users.J Subst Abuse Treat2021
33748808COVID-19: A new barrier to treatment for opioid use disorder in the emergency department.J Am Coll Emerg Physicians Open2021
31399272Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.J Subst Abuse Treat2020
31737965The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?Addiction2020
33028467Putting the Horse Before the Unicorn: A Safe Supply Strategy Should Begin With Partial Agonists--A Commentary on Bonn et al. (2020).J Stud Alcohol Drugs2020
32163431Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial.PLoS One2020
30577904Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system.J Subst Abuse Treat2019
31495375Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks, Offering a Public Health Perspective-A Commentary on Camenga et al.J Stud Alcohol Drugs2019
31362002Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.Prev Med2019
28527854Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders.J Subst Abuse Treat2018
29800622Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.Behav Res Ther2018
29852309Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.Behav Res Ther2018
28291571The Los Angeles County hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in Los Angeles County (2010-2015).J Subst Abuse Treat2018
29300100Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.J Consult Clin Psychol2018
29174308Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up.J Subst Abuse Treat2018
29159398Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California.Ann Intern Med2018
27861439Trends in Tramadol: Pharmacology, Metabolism, and Misuse.Anesth Analg2017
28191264Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial.Mindfulness (N Y)2017
28493265National Rehabilitation Center programme performance measures in the United Arab Emirates, 2013.East Mediterr Health J2017
28238214Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014.Addiction2017
26158698A demonstration project implementing extended-release naltrexone in Los Angeles County.Subst Abus2016
26503310Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.Neuropsychopharmacology2016
27341852A Cognitive Behavioral Therapy-Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users: Study Protocol for a Pilot Randomized Trial.JMIR Res Protoc2016
27568505Organizing Publicly Funded Substance Use Disorder Treatment in the United States: Moving Toward a Service System Approach.J Subst Abuse Treat2016
26830141Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.Mol Psychiatry2016
26823295Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County.J Subst Abuse Treat2016
25747927The globalization of addiction research: capacity-building mechanisms and selected examples.Harv Rev Psychiatry2015
26371404Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.Drug Alcohol Depend2015
25907813Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.Am J Addict2015
25934458The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting.J Subst Abuse Treat2015
17383002Children exposed to methamphetamine use and manufacture.Child Abuse Negl2014
26752803Addiction Science: A Rationale and Tools for a Public Health Response to Drug Abuse.Public Health Rev2014
25984282Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts.Addict Health2014
25489445Behaviors Influencing Human Immunodeficiency Virus Transmission in the Context of Positive Prevention among People Living with HIV/Acquired Immunodeficiency Syndrome in Iran: A Qualitative Study.Int J Prev Med2014
25110333Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.Drug Alcohol Depend2014
24827867Drug and alcohol use in Iraq: findings of the inaugural Iraqi Community Epidemiological Workgroup.Subst Use Misuse2014
  • 1 - 50 of 231

Recommended Authors

Division of General Internal Medicine and Health Services Research.
Career Start Year 2017
Number of shared co-authors 2
David Geffen School of Medicine at University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 2
University of Cincinnati College of Medicine
Career Start Year 2011
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Kaiser Permanente Northwest Center for Health Research
Career Start Year 2009
Number of shared co-authors 0
Rockefeller Neuroscience Institute, West Virginia University
Career Start Year 2006
Number of shared co-authors 0
University of Washington
Career Start Year 2005
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 0
West Virginia University, School of Public Health
Career Start Year 2005
Number of shared co-authors 0
VA Connecticut Healthcare System
Career Start Year 2004
Number of shared co-authors 0
Kaiser Permanente Northern California
Career Start Year 2003
Number of shared co-authors 0
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 0
University of California San Francisco, Kaiser Permanente Northern California
Career Start Year 2001
Number of shared co-authors 0
Clinical Care, University of Utah School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Career Start Year 2000
Number of shared co-authors 0
The University of Chicago
Career Start Year 1999
Number of shared co-authors 0
Center for Access and Delivery Research and Evaluation (CADRE)
Career Start Year 1998
Number of shared co-authors 0
University of Wisconsin-Madison School of Pharmacy.
Career Start Year 1994
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1992
Number of shared co-authors 1
Yale School of Public Health, United States Yale School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Brandeis University, Institute for Behavioral Health
Career Start Year 1987
Number of shared co-authors 0
VA Connecticut Healthcare System.
Career Start Year 1987
Number of shared co-authors 0
Kaiser Permanente Northern California
Career Start Year 1986
Number of shared co-authors 0
The University of New Mexico
Career Start Year 1984
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 0
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 0
Columbia University and the New York State Psychiatric Institute
Career Start Year 1980
Number of shared co-authors 1
Health Services Research and Development Service
Career Start Year 1976
Number of shared co-authors 0
College of Medicine, Medical University of South Carolina
Career Start Year 1975
Number of shared co-authors 1

Collaborators

University of California Los Angeles
Co-authored papers 46
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 20
university of california los angeles Integrated Substance Abuse Programs
Co-authored papers 10
University of California at Los Angeles
Co-authored papers 9
Brain Research Institute, University of California at Los Angeles
Co-authored papers 7
University of California at Irvine
Co-authored papers 4
University of California at San Diego
Co-authored papers 2
University of California los angeles
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Pacific Neuroscience Institute and Foundation
Co-authored papers 1
Dana and David Dornsife College of Letters, University of Southern California
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
University of Southern California
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
VA San Diego Healthcare System
Co-authored papers 1
Alfred P. Sloan Foundation, National Academy of Sciences, University of California Berkeley, University of California San Diego, University of California, San Diego
Co-authored papers 1
Co-authored papers 1
University of Maryland School of Medicine
Co-authored papers 1
The David Geffen School of Medicine at the University of California Los Angeles
Co-authored papers 1